Researchers developed a saliva based SERS platform that detects epilepsy, Parkinson's disease, and schizophrenia by analyzing protein structural changes with up to 98% accuracy.

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease which affects 3 million people worldwide.

Researchers at the MPI of Biochemistry and TUM have examined the cerebrospinal fluid of 5,000 patients with neurological diseases and discovered new diagnostic and prognostic markers for multiple ...

Introduction Onchocerciasis, commonly known as river blindness, is a parasitic disease caused by Onchocerca volvulus affecting millions predominantly in sub-Saharan Africa. Robust epidemiological ...

Introduction: Delayed cerebral ischemia is the most widely recognized mediator of secondary brain injury in aneurysmal subarachnoid hemorrhage (aSAH), primarily resulting from toxic, blood byproducts ...

Despite durable viral suppression, neuroinflammation and neurocognitive complications remain common yet poorly understood in people with HIV (PWH). HIV alters human viromes, and virome perturbations ...

Built on Alamar's proprietary NULISA™ platform, the NULISAqpcr BD-pTau217 Assay delivers unprecedented sensitivity and specificity from non-invasive sample types such as plasma, serum and dried blood ...

Background Oligoclonal bands (OCBs) and Kappa free light chains (FLCs) in the cerebrospinal fluid (CSF) are sensitive markers of intrathecal immunoglobulin (Ig)G synthesis in patients with multiple ...

Proteomic analysis of cerebrospinal fluid (CSF) has the potential to provide insight into the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH) and target trials to improve outcome. The aim ...

INDIANAPOLIS (WISH) — An estimated 7.2 million Americans aged 65 years and older have Alzheimer’s dementia (equating to about 1 in 9 Americans) and this figure is expected to double by 2060. Globally, ...